Yes, targeting metabolic pathways presents a promising therapeutic approach. Inhibitors of glycolysis, such as 2-deoxyglucose, are being explored for their potential to starve cancer cells of energy. Inhibiting glutaminase can disrupt glutamine metabolism, impairing cell growth. Furthermore, drugs targeting lipid metabolism and redox balance are under investigation to selectively kill cancer cells.
